## **Core Concept**
Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), acts by irreversibly inhibiting the enzyme **cyclooxygenase (COX)**, which is crucial for the synthesis of **thromboxanes** and **prostaglandins**. This inhibition affects platelet aggregation and inflammation.

## **Why the Correct Answer is Right**
The correct answer, **Bleeding Time**, increases with aspirin use because aspirin's inhibition of **COX-1** reduces the production of **thromboxane A2** in platelets. Thromboxane A2 is essential for platelet aggregation. With decreased thromboxane A2, platelets are less able to aggregate, leading to an increased bleeding time. This effect is irreversible for the lifespan of the platelet (about 7-10 days), which is why the effect of a single dose of aspirin lasts for the lifespan of the platelet.

## **Why Each Wrong Option is Incorrect**
- **Option A:** *Prothrombin Time (PT)* is a test used to evaluate the extrinsic and common coagulation pathways. Aspirin does not significantly affect these pathways directly; hence, PT is not typically prolonged by aspirin.
- **Option B:** *Partial Thromboplastin Time (PTT)* assesses the intrinsic and common coagulation pathways. Aspirin has a minimal effect on these pathways; therefore, PTT is not significantly increased by aspirin.
- **Option C:** *Plasma fibrinogen* levels are not directly affected by aspirin's mechanism of action. Aspirin works on platelets, not on the production or degradation of fibrinogen.

## **Clinical Pearl / High-Yield Fact**
Aspirin-induced bleeding risk is a critical consideration, especially in patients undergoing surgery or with a history of gastrointestinal bleeding. A simple clinical correlation to remember is that **aspirin affects platelet function, not coagulation factors**, which is why it primarily affects bleeding time rather than PT or PTT.

## **Correct Answer:** D. Bleeding Time